pharma · AML With Gene Mutations
Lomond Therapeutics Holdings
Lomond Therapeutics Holdings patent portfolio — 0 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
CN HQ
NMPA registrant Type
Company details
- Status
- Public
- HQ
- CN
- Programs
- 1
- Drugs
- 1
- Patents
- 0
Lomond Therapeutics Holdings patents
0 pharmaceutical patents indexed for Lomond Therapeutics Holdings. 0 expire within 24 months.
Lomond Therapeutics Holdings has 0 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
No patents matched
Frequently asked questions
How many patents does Lomond Therapeutics Holdings have?
0 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Lomond Therapeutics Holdings patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.